PROVE data released on telaprevir.
D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D015507:Drugs, Investigational; D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir